[Therapy of hirsutism with cyproterone acetate (author's transl)].
21 female patients with pronounced, predominantly idiopathic hirsutism were treated for six month wit preparation SH B 209 AB (Diane, Schering corp.) supplemented by 10 mg Cyproterone acetate between the 5th and 20th day of the menstrual cycle. The results of this therapy were clinically assessed as excellent in 5 patients, 11 patients showed a considerable, and 4 a moderate reduction of hirsutism, 1 patient showed no improvement. The results were quantified by measurement of hair thickness. In almost all cases a reduction was found, the mean value being 18,74%. No correlation could be found between therapeutic success and menstrual cycle anamnesis.
D000293:Adolescent; D000328:Adult; D002648:Child; D003534:Cyproterone / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006628:Hirsutism / Q000188:drug therapy*; D006801:Humans; D008598:Menstruation / Q000187:drug effects
D003534:Cyproterone
Behandlung des Hirsutismus mit Cyproteronacetat.